<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Medical Drugs Articles in Medical XPRT</title><link>https://alpha.medical-xprt.com/medical-drugs/articles</link><description>Medical Drugs Articles in Medical XPRT</description><image><url>https://alpha.medical-xprt.com/images/logo.gif</url><link>https://alpha.medical-xprt.com/medical-drugs/articles</link><title>Medical Drugs Articles in Medical XPRT</title></image><item><title>Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders</title><link>https://alpha.medical-xprt.com/news/scopus-biopharma-announces-adjournment-of-annual-meeting-of-stockholders-1099209</link><description><![CDATA[New York, New York, November 8, 2021 &ndash; Scopus BioPharma Inc. (Nasdaq: &ldquo;SCPS&rdquo;) today announced that, on November 5, 2021, its 2021 Annual Meeting of Stockholders (the &ldquo;Annual Meeting&rdquo;) was adjourned to 11:30 a.m., Eastern time, on Monday, December 20, 2021, without any business being conducted. The adjourned meeting will be held by means of remote communication and can be accessed via the following URL: http://www.cesonlineservices.com/scps21_vm. The adjournment date is pursuant to an understanding between Scopus and Morris C. Laster, M.D. in connection with Dr. Laster&rsquo;s pending litigation against Scopus in the Delaware Court of Chancery. The record date for the Annual Meeting will remain August 16, 2021. ]]></description><pubDate>Mon, 08 Nov 2021 00:00:00 +0000</pubDate><guid>https://alpha.medical-xprt.com/news/scopus-biopharma-announces-adjournment-of-annual-meeting-of-stockholders-1099209</guid><category>biopharmaceutical</category></item></channel></rss>
